Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.36 USD | +2.22% | +7.17% | +169.17% |
04-04 | Avidity Biosciences Insider Sold Shares Worth $734,919, According to a Recent SEC Filing | MT |
04-04 | Avidity Biosciences Insider Sold Shares Worth $542,214, According to a Recent SEC Filing | MT |
Sales 2024 * | 13.46M 1.08B | Sales 2025 * | 10.5M 841M | Capitalization | 2.33B 186B |
---|---|---|---|---|---|
Net income 2024 * | -274M -21.93B | Net income 2025 * | -321M -25.7B | EV / Sales 2024 * | 119 x |
Net cash position 2024 * | 722M 57.76B | Net cash position 2025 * | 431M 34.53B | EV / Sales 2025 * | 181 x |
P/E ratio 2024 * |
-7.77
x | P/E ratio 2025 * |
-6.9
x | Employees | 253 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.59% |
Latest transcript on Avidity Biosciences, Inc.
1 day | +2.22% | ||
1 week | +7.17% | ||
Current month | -4.55% | ||
1 month | -1.26% | ||
3 months | +102.33% | ||
6 months | +400.21% | ||
Current year | +169.17% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
FOU | Founder | 55 | 12/11/12 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 30/09/19 |
Michael MacLean
DFI | Director of Finance/CFO | 58 | 18/05/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 30/09/13 |
Carsten Boess
BRD | Director/Board Member | 57 | 12/04/20 |
Edward Kaye
BRD | Director/Board Member | 75 | 21/08/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 24.36 | +2.22% | 1,034,630 |
25/04/24 | 23.83 | -5.02% | 1,247,373 |
24/04/24 | 25.09 | -0.20% | 559,826 |
23/04/24 | 25.14 | +4.06% | 859,072 |
22/04/24 | 24.16 | +6.29% | 911,773 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+169.17% | 2.33B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- RNA Stock